R H. Monoclonal Antibody Therapy in Early Alzheimer’s disease: a Review of Lecanemab and Aducanumab. Biospecia [Internet]. 2026 Apr. 2 [cited 2026 Apr. 22];2(1):1-6. Available from: https://uniquepubinternational.com/journals/index.php/biospecia/article/view/182